Implementing Depression and Adherence Treatment

NCT ID: NCT07032363

Last Updated: 2025-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2029-01-20

Study Completion Date

2034-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare a core set and enhanced set of implementation strategies in increasing the reach of evidence-based treatments to patients with HIV and depression. The main questions it aims to answer are:

What proportion of patients start an evidence-based treatment for depression (reach)? What percentage of patients show clinical improvement in depression and what percentage attain viral undetectability within one year (effectiveness)?

Researchers will compare high and low reach clinics to further inform tailored implementation strategies for uptake and maintenance.

Clinics will be randomized into one of two study arms: core versus enhanced strategies. In both arms, core strategies will be utilized. Enhanced clinics will also receive more resource-intensive training.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression HIV Adherence, Treatment AIDS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Core

Clinics in this arm will receive strategies that involve capacity building for nurses and education on mental health.

Group Type OTHER

Core Implementation Strategies

Intervention Type OTHER

* Task Sharing/Revise Professional Roles
* Distribute educational materials/Dynamic Training/Address Stigma
* Clinician Implementation Team Meetings
* Partner with CoCT DoH
* Champion
* Audit and Feedback
* Stage Scale Up/Tailoring

Enhanced

Clinics in the enhanced arm will receive core strategies along with enhanced strategies that involve more intensive training on depression treatment.

Group Type OTHER

Core Implementation Strategies

Intervention Type OTHER

* Task Sharing/Revise Professional Roles
* Distribute educational materials/Dynamic Training/Address Stigma
* Clinician Implementation Team Meetings
* Partner with CoCT DoH
* Champion
* Audit and Feedback
* Stage Scale Up/Tailoring

Enhanced Implementation Strategies

Intervention Type OTHER

* Train the trainer
* Ongoing supervision and consultation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Core Implementation Strategies

* Task Sharing/Revise Professional Roles
* Distribute educational materials/Dynamic Training/Address Stigma
* Clinician Implementation Team Meetings
* Partner with CoCT DoH
* Champion
* Audit and Feedback
* Stage Scale Up/Tailoring

Intervention Type OTHER

Enhanced Implementation Strategies

* Train the trainer
* Ongoing supervision and consultation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinics are eligible if they provide HIV primary care via the City of Cape Town (CoCT) Department of Health
* Clinics will be assigned to the study upon notice of funding and before start up.


Although the unit of randomization is at the clinic level, the study will be looking at adult patient level data at each clinic. All patients engaged in care at one of the 10 primary care/HIV treatment clinics included in the study will be eligible to enroll if they:

* Are 18 years of age or older and
* Have a detectable HIV viral load (operationalized as the lower limit of detection on the standard test is used at the local clinic).
* Screen in for depression on the PHq-9 (score of 10 or above).


* For the qualitative data which involve interviewing clinic staff (specifically, nurses, physicians, clinic managers, or other involved in implementation) and patients, individuals will be eligible to participate if they are:
* employees (occupying the pre-specified roles) or patients (who met eligibility criteria for the implementation phase, regardless of whether or not they choose to enroll in the implementation phase) of a clinic that was randomized to the experimental condition.
* Clinic staff will be 18 years and older

Exclusion Criteria

-Children below the age of 18 will not be included in the proposed study for adults.


\- Children less than 18 will not be included
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

Massachusetts General Hospital

OTHER

Sponsor Role collaborator

University of Miami

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Steven Safren

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Miami

Miami, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Everitt-Penhale B, Kagee A, Magidson JF, Joska J, Safren SA, O'Cleirigh C, Witten J, Lee JS, Andersen LS. 'I went back to being myself': acceptability of a culturally adapted task-shifted cognitive-behavioural therapy (CBT) treatment for depression (Ziphamandla) for South African HIV care settings. Psychol Health Med. 2019 Jul;24(6):680-690. doi: 10.1080/13548506.2019.1566624. Epub 2019 Jan 17.

Reference Type BACKGROUND
PMID: 30652921 (View on PubMed)

Safren SA, Bedoya CA, O'Cleirigh C, Biello KB, Pinkston MM, Stein MD, Traeger L, Kojic E, Robbins GK, Lerner JA, Herman DS, Mimiaga MJ, Mayer KH. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial. Lancet HIV. 2016 Nov;3(11):e529-e538. doi: 10.1016/S2352-3018(16)30053-4. Epub 2016 Sep 19.

Reference Type BACKGROUND
PMID: 27658881 (View on PubMed)

Safren SA, O'Cleirigh C, Andersen LS, Magidson JF, Lee JS, Bainter SA, Musinguzi N, Simoni J, Kagee A, Joska JA. Treating depression and improving adherence in HIV care with task-shared cognitive behavioural therapy in Khayelitsha, South Africa: a randomized controlled trial. J Int AIDS Soc. 2021 Oct;24(10):e25823. doi: 10.1002/jia2.25823.

Reference Type BACKGROUND
PMID: 34708929 (View on PubMed)

Safren SA, O'Cleirigh C, Tan JY, Raminani SR, Reilly LC, Otto MW, Mayer KH. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009 Jan;28(1):1-10. doi: 10.1037/a0012715.

Reference Type BACKGROUND
PMID: 19210012 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01MH136972

Identifier Type: NIH

Identifier Source: secondary_id

View Link

20241034

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Linkage to Care - Part I
NCT00703040 COMPLETED
The Test-to-PrEP Study
NCT06927856 RECRUITING NA